AbbVie
ABBV
#25
Rank
A$752.36 B
Marketcap
A$425.64
Share price
-2.33%
Change (1 day)
18.10%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of November 2026 (TTM): 7.68

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -86.2. At the end of 2026 the company had a P/S ratio of 7.04.

P/S ratio history for AbbVie from 2012 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20267.046.17%
20256.6318.67%
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.52-67.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.3 86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.18-19.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.62-52.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.75-12.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.46-68.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.46-41.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.19-71.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
4.49-41.52%๐Ÿ‡บ๐Ÿ‡ธ USA